[
    {
        "id": 4611,
        "drug_name": "AJOVY (fremanezumab)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Migraine",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2018-09-14",
        "link": "http:\/\/ir.tevapharm.com\/phoenix.zhtml?c=73925&p=RssLanding&cat=news&id=2367586",
        "note": "FDA Approval announced September 14, 2018.",
        "company_entity_id": 390,
        "company_ticker": "TEVA",
        "company_name": "Teva Pharmaceutical Industries Limited American Depositary Shares",
        "company_price": "13.4900",
        "company_change": 0.14,
        "company_percent_change": 1.05,
        "company_optionable": 1,
        "company_number_of_shares": 1121094011,
        "price_change_sparkline": [
            [
                12.1,
                1706677200
            ],
            [
                12.46,
                1706763600
            ],
            [
                12.28,
                1706850000
            ],
            [
                12.38,
                1707109200
            ],
            [
                12.25,
                1707195600
            ],
            [
                12.14,
                1707282000
            ],
            [
                12.09,
                1707368400
            ],
            [
                12.01,
                1707454800
            ],
            [
                12.91,
                1707714000
            ],
            [
                12.92,
                1707800400
            ],
            [
                13.17,
                1707886800
            ],
            [
                13.2,
                1707973200
            ],
            [
                13.02,
                1708059600
            ],
            [
                13.07,
                1708405200
            ],
            [
                13,
                1708491600
            ],
            [
                13.05,
                1708578000
            ],
            [
                12.89,
                1708664400
            ],
            [
                13.29,
                1708923600
            ],
            [
                13.3,
                1709010000
            ],
            [
                13.09,
                1709096400
            ],
            [
                13.15,
                1709182800
            ],
            [
                13.5,
                1709269200
            ],
            [
                13.44,
                1709528400
            ],
            [
                13.54,
                1709614800
            ],
            [
                13.53,
                1709701200
            ],
            [
                13.71,
                1709787600
            ],
            [
                13.62,
                1709874000
            ],
            [
                13.35,
                1710129600
            ],
            [
                13.49,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 3584,
        "drug_name": "COPIKTRA (duvelisib)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Chronic lymphocytic leukemia (CLL)\/\/Small Lymphocytic Lymphoma (SLL)\/Follicular Lymphoma",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2018-09-24",
        "link": "http:\/\/investor.verastem.com\/phoenix.zhtml?c=250749&p=irol-newsArticle&ID=2368647",
        "note": "FDA Approval announced September 24, 2018.",
        "company_entity_id": 308,
        "company_ticker": "VSTM",
        "company_name": "Verastem Inc.",
        "company_price": "10.8400",
        "company_change": -0.6,
        "company_percent_change": -5.24,
        "company_optionable": 1,
        "company_number_of_shares": 25268102,
        "price_change_sparkline": [
            [
                11.75,
                1706677200
            ],
            [
                12.25,
                1706763600
            ],
            [
                12.25,
                1706850000
            ],
            [
                12.3,
                1707109200
            ],
            [
                14.07,
                1707195600
            ],
            [
                13.45,
                1707282000
            ],
            [
                13.45,
                1707368400
            ],
            [
                13.22,
                1707454800
            ],
            [
                11.86,
                1707714000
            ],
            [
                11.74,
                1707800400
            ],
            [
                11.86,
                1707886800
            ],
            [
                11.74,
                1707973200
            ],
            [
                12.45,
                1708059600
            ],
            [
                12.67,
                1708405200
            ],
            [
                12.33,
                1708491600
            ],
            [
                12.04,
                1708578000
            ],
            [
                12.7,
                1708664400
            ],
            [
                13.09,
                1708923600
            ],
            [
                13.12,
                1709010000
            ],
            [
                12.81,
                1709096400
            ],
            [
                12.46,
                1709182800
            ],
            [
                13.02,
                1709269200
            ],
            [
                12.69,
                1709528400
            ],
            [
                12.4,
                1709614800
            ],
            [
                12.69,
                1709701200
            ],
            [
                11.79,
                1709787600
            ],
            [
                11.57,
                1709874000
            ],
            [
                11.44,
                1710129600
            ],
            [
                10.84,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 4507,
        "drug_name": "Symjepi - low dose",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Anaphylaxis",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2018-09-27",
        "link": "http:\/\/ir.adamispharmaceuticals.com\/news-releases\/news-release-details\/adamis-pharmaceuticals-receives-fda-approval-its-lower-dose",
        "note": "FDA Approval announced September 27, 2018.",
        "company_entity_id": 15,
        "company_ticker": "ADMP",
        "company_name": "DMK Pharmaceuticals Corp Com Par $0.001",
        "company_price": "0.7751",
        "company_change": 0.01,
        "company_percent_change": 0.85,
        "company_optionable": 0,
        "company_number_of_shares": 9359133,
        "statuses": []
    },
    {
        "id": 2179,
        "drug_name": "LIBTAYO (cemiplimab)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Cutaneous squamous cell carcinoma",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2018-09-28",
        "link": "https:\/\/investor.regeneron.com\/news-releases\/news-release-details\/fda-approves-libtayor-cemiplimab-rwlc-first-and-only-treatment",
        "note": "FDA Approval announced September 28, 2018.",
        "company_entity_id": 388,
        "company_ticker": "REGN",
        "company_name": "Regeneron Pharmaceuticals Inc.",
        "company_price": "970.5700",
        "company_change": 6.13,
        "company_percent_change": 0.64,
        "company_optionable": 1,
        "company_number_of_shares": 109761896,
        "price_change_sparkline": [
            [
                942.78,
                1706677200
            ],
            [
                957.78,
                1706763600
            ],
            [
                945.18,
                1706850000
            ],
            [
                936.33,
                1707109200
            ],
            [
                937.81,
                1707195600
            ],
            [
                938.49,
                1707282000
            ],
            [
                946.43,
                1707368400
            ],
            [
                953.42,
                1707454800
            ],
            [
                947.06,
                1707714000
            ],
            [
                940.48,
                1707800400
            ],
            [
                947.82,
                1707886800
            ],
            [
                954.73,
                1707973200
            ],
            [
                948.05,
                1708059600
            ],
            [
                946.87,
                1708405200
            ],
            [
                952.84,
                1708491600
            ],
            [
                964.89,
                1708578000
            ],
            [
                981.2,
                1708664400
            ],
            [
                989.28,
                1708923600
            ],
            [
                993.35,
                1709010000
            ],
            [
                987.61,
                1709096400
            ],
            [
                966.09,
                1709182800
            ],
            [
                982.82,
                1709269200
            ],
            [
                971.19,
                1709528400
            ],
            [
                965.21,
                1709614800
            ],
            [
                972.1,
                1709701200
            ],
            [
                973.31,
                1709787600
            ],
            [
                968.83,
                1709874000
            ],
            [
                964.44,
                1710129600
            ],
            [
                970.57,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 2179,
        "drug_name": "LIBTAYO (cemiplimab)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Cutaneous squamous cell carcinoma",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2018-09-28",
        "link": "https:\/\/investor.regeneron.com\/news-releases\/news-release-details\/fda-approves-libtayor-cemiplimab-rwlc-first-and-only-treatment",
        "note": "FDA Approval announced September 28, 2018.",
        "company_entity_id": 389,
        "company_ticker": "SNY",
        "company_name": "Sanofi",
        "company_price": "48.4600",
        "company_change": 0.11,
        "company_percent_change": 0.23,
        "company_optionable": 1,
        "company_number_of_shares": 2529599938,
        "price_change_sparkline": [
            [
                49.9,
                1706677200
            ],
            [
                48.41,
                1706763600
            ],
            [
                47.23,
                1706850000
            ],
            [
                46.95,
                1707109200
            ],
            [
                47.06,
                1707195600
            ],
            [
                46.92,
                1707282000
            ],
            [
                46.56,
                1707368400
            ],
            [
                46.5,
                1707454800
            ],
            [
                46.34,
                1707714000
            ],
            [
                45.75,
                1707800400
            ],
            [
                45.8,
                1707886800
            ],
            [
                46.39,
                1707973200
            ],
            [
                46.18,
                1708059600
            ],
            [
                46.85,
                1708405200
            ],
            [
                47.92,
                1708491600
            ],
            [
                47.8,
                1708578000
            ],
            [
                48.77,
                1708664400
            ],
            [
                48.2,
                1708923600
            ],
            [
                48.21,
                1709010000
            ],
            [
                48,
                1709096400
            ],
            [
                47.85,
                1709182800
            ],
            [
                47.29,
                1709269200
            ],
            [
                47.15,
                1709528400
            ],
            [
                47.5,
                1709614800
            ],
            [
                47.68,
                1709701200
            ],
            [
                48.06,
                1709787600
            ],
            [
                48.25,
                1709874000
            ],
            [
                48.35,
                1710129600
            ],
            [
                48.46,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 2576,
        "drug_name": "EMGALITY (galcanezumab)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Migraine prevention",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2018-09-28",
        "link": "https:\/\/www.prnewswire.com\/news-releases\/lillys-emgality-galcanezumab-gnlm-receives-us-fda-approval-for-the-preventive-treatment-of-migraine-in-adults-300720720.html",
        "note": "FDA approval announced September 27, 2018.",
        "company_entity_id": 382,
        "company_ticker": "LLY",
        "company_name": "Eli Lilly and Company",
        "company_price": "754.9500",
        "company_change": 20.58,
        "company_percent_change": 2.8,
        "company_optionable": 1,
        "company_number_of_shares": 950164452,
        "price_change_sparkline": [
            [
                644.503643637706,
                1706677200
            ],
            [
                659.298247188938,
                1706763600
            ],
            [
                666.505874560051,
                1706850000
            ],
            [
                704.989812947364,
                1707109200
            ],
            [
                703.821817930162,
                1707195600
            ],
            [
                724.13694493877,
                1707282000
            ],
            [
                734.41929423551,
                1707368400
            ],
            [
                738.891617036422,
                1707454800
            ],
            [
                735.996586651903,
                1707714000
            ],
            [
                741.696801650387,
                1707800400
            ],
            [
                757.31,
                1707886800
            ],
            [
                757.78,
                1707973200
            ],
            [
                782.06,
                1708059600
            ],
            [
                755.66,
                1708405200
            ],
            [
                745.91,
                1708491600
            ],
            [
                769.64,
                1708578000
            ],
            [
                769.54,
                1708664400
            ],
            [
                771.92,
                1708923600
            ],
            [
                765,
                1709010000
            ],
            [
                757.64,
                1709096400
            ],
            [
                753.68,
                1709182800
            ],
            [
                782.12,
                1709269200
            ],
            [
                792.28,
                1709528400
            ],
            [
                777.59,
                1709614800
            ],
            [
                779.77,
                1709701200
            ],
            [
                780.16,
                1709787600
            ],
            [
                762.14,
                1709874000
            ],
            [
                734.37,
                1710129600
            ],
            [
                754.95,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 5061,
        "drug_name": "ARIKAYCE",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Nontuberculous mycobacterial (NTM) lung disease",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2018-09-28",
        "link": "https:\/\/www.nasdaq.com\/press-release\/insmed-announces-fda-approval-of-arikayce-amikacin-liposome-inhalation-suspension-the-first-and-20180928-00835",
        "note": "FDA Approval announced September 28, 2018.",
        "company_entity_id": 171,
        "company_ticker": "INSM",
        "company_name": "Insmed Incorporated",
        "company_price": "27.3100",
        "company_change": 0.23,
        "company_percent_change": 0.85,
        "company_optionable": 1,
        "company_number_of_shares": 148491583,
        "price_change_sparkline": [
            [
                27.8,
                1706677200
            ],
            [
                28.53,
                1706763600
            ],
            [
                28.18,
                1706850000
            ],
            [
                28.28,
                1707109200
            ],
            [
                29.07,
                1707195600
            ],
            [
                28.99,
                1707282000
            ],
            [
                28.57,
                1707368400
            ],
            [
                28.25,
                1707454800
            ],
            [
                27.8,
                1707714000
            ],
            [
                26.6,
                1707800400
            ],
            [
                27.44,
                1707886800
            ],
            [
                28.75,
                1707973200
            ],
            [
                29.51,
                1708059600
            ],
            [
                29.21,
                1708405200
            ],
            [
                28.24,
                1708491600
            ],
            [
                27.15,
                1708578000
            ],
            [
                27.28,
                1708664400
            ],
            [
                28.75,
                1708923600
            ],
            [
                29.23,
                1709010000
            ],
            [
                28.03,
                1709096400
            ],
            [
                27.72,
                1709182800
            ],
            [
                28.06,
                1709269200
            ],
            [
                28.27,
                1709528400
            ],
            [
                27.82,
                1709614800
            ],
            [
                27.99,
                1709701200
            ],
            [
                27.77,
                1709787600
            ],
            [
                27.82,
                1709874000
            ],
            [
                27.08,
                1710129600
            ],
            [
                27.31,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 2991,
        "drug_name": "KYPROLIS (ARROW)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Multiple Myeloma",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2018-10-01",
        "link": "http:\/\/investors.amgen.com\/phoenix.zhtml?c=61656&p=irol-newsArticle&ID=2369600",
        "note": "FDA approval announced October 1, 2018.",
        "company_entity_id": 627,
        "company_ticker": "LGND",
        "company_name": "Ligand Pharmaceuticals Incorporated",
        "company_price": "72.3600",
        "company_change": 0.11,
        "company_percent_change": 0.15,
        "company_optionable": 1,
        "company_number_of_shares": 17705287,
        "price_change_sparkline": [
            [
                73.1,
                1706677200
            ],
            [
                74.17,
                1706763600
            ],
            [
                74.54,
                1706850000
            ],
            [
                74.72,
                1707109200
            ],
            [
                75.31,
                1707195600
            ],
            [
                74.51,
                1707282000
            ],
            [
                75.41,
                1707368400
            ],
            [
                75.88,
                1707454800
            ],
            [
                75.64,
                1707714000
            ],
            [
                71,
                1707800400
            ],
            [
                73.62,
                1707886800
            ],
            [
                74.65,
                1707973200
            ],
            [
                73.66,
                1708059600
            ],
            [
                72.37,
                1708405200
            ],
            [
                72.67,
                1708491600
            ],
            [
                73.56,
                1708578000
            ],
            [
                75.87,
                1708664400
            ],
            [
                74.42,
                1708923600
            ],
            [
                89.2,
                1709010000
            ],
            [
                84.35,
                1709096400
            ],
            [
                79.35,
                1709182800
            ],
            [
                78.7,
                1709269200
            ],
            [
                76.28,
                1709528400
            ],
            [
                74,
                1709614800
            ],
            [
                72.71,
                1709701200
            ],
            [
                72.47,
                1709787600
            ],
            [
                73.77,
                1709874000
            ],
            [
                72.25,
                1710129600
            ],
            [
                72.36,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 2991,
        "drug_name": "KYPROLIS (ARROW)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Multiple Myeloma",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2018-10-01",
        "link": "http:\/\/investors.amgen.com\/phoenix.zhtml?c=61656&p=irol-newsArticle&ID=2369600",
        "note": "FDA approval announced October 1, 2018.",
        "company_entity_id": 372,
        "company_ticker": "AMGN",
        "company_name": "Amgen Inc.",
        "company_price": "276.5400",
        "company_change": 1.18,
        "company_percent_change": 0.43,
        "company_optionable": 1,
        "company_number_of_shares": 535918901,
        "price_change_sparkline": [
            [
                311.832823699025,
                1706677200
            ],
            [
                322.053272003295,
                1706763600
            ],
            [
                320.693853151174,
                1706850000
            ],
            [
                319.483275779212,
                1707109200
            ],
            [
                313.62884422628,
                1707195600
            ],
            [
                293.584858231498,
                1707282000
            ],
            [
                292.572736166415,
                1707368400
            ],
            [
                288.871544693121,
                1707454800
            ],
            [
                292.155980021969,
                1707714000
            ],
            [
                288.236487711108,
                1707800400
            ],
            [
                287.829654332006,
                1707886800
            ],
            [
                289.07,
                1707973200
            ],
            [
                283.7,
                1708059600
            ],
            [
                283.51,
                1708405200
            ],
            [
                283.46,
                1708491600
            ],
            [
                285.18,
                1708578000
            ],
            [
                289.18,
                1708664400
            ],
            [
                286.37,
                1708923600
            ],
            [
                278.49,
                1709010000
            ],
            [
                277.46,
                1709096400
            ],
            [
                273.83,
                1709182800
            ],
            [
                280.33,
                1709269200
            ],
            [
                279.39,
                1709528400
            ],
            [
                276.65,
                1709614800
            ],
            [
                276.59,
                1709701200
            ],
            [
                272.86,
                1709787600
            ],
            [
                273.75,
                1709874000
            ],
            [
                275.36,
                1710129600
            ],
            [
                276.54,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 4130,
        "drug_name": "XYOSTED (testosterone enanthate)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Testosterone deficiency",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2018-10-01",
        "link": "https:\/\/seekingalpha.com\/pr\/17285530-antares-receives-fda-approval-xyosted-testosterone-enanthate-injection-testosterone",
        "note": "FDA Approval announced October 1, 2018.",
        "company_entity_id": 156,
        "company_ticker": "HALO",
        "company_name": "Halozyme Therapeutics Inc.",
        "company_price": "41.9500",
        "company_change": 0.75,
        "company_percent_change": 1.8199999999999998,
        "company_optionable": 1,
        "company_number_of_shares": 126824800,
        "price_change_sparkline": [
            [
                33.85,
                1706677200
            ],
            [
                34.26,
                1706763600
            ],
            [
                33.68,
                1706850000
            ],
            [
                33.68,
                1707109200
            ],
            [
                35.02,
                1707195600
            ],
            [
                35.31,
                1707282000
            ],
            [
                35.24,
                1707368400
            ],
            [
                35.49,
                1707454800
            ],
            [
                35.69,
                1707714000
            ],
            [
                34.64,
                1707800400
            ],
            [
                35.06,
                1707886800
            ],
            [
                35.91,
                1707973200
            ],
            [
                36.1,
                1708059600
            ],
            [
                36,
                1708405200
            ],
            [
                38.36,
                1708491600
            ],
            [
                39.72,
                1708578000
            ],
            [
                40.56,
                1708664400
            ],
            [
                39.67,
                1708923600
            ],
            [
                39.84,
                1709010000
            ],
            [
                39.69,
                1709096400
            ],
            [
                39.81,
                1709182800
            ],
            [
                41.11,
                1709269200
            ],
            [
                40.93,
                1709528400
            ],
            [
                41.41,
                1709614800
            ],
            [
                41.69,
                1709701200
            ],
            [
                41.71,
                1709787600
            ],
            [
                41.73,
                1709874000
            ],
            [
                41.2,
                1710129600
            ],
            [
                41.95,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 4820,
        "drug_name": "HEMLIBRA (emicizumab)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Hemophilia",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2018-10-04",
        "link": "https:\/\/www.roche.com\/investors\/updates\/inv-update-2018-10-04c.htm",
        "note": "FDA Approval announced October 4, 2018.",
        "company_entity_id": 536,
        "company_ticker": "RHHBY",
        "company_name": "Roche Holding AG ADR",
        "company_price": "35.1500",
        "company_change": 0.54,
        "company_percent_change": 1.56,
        "company_optionable": 0,
        "company_number_of_shares": 6389213336,
        "price_change_sparkline": [
            [
                35.14,
                1706677200
            ],
            [
                34.32,
                1706763600
            ],
            [
                33.95,
                1706850000
            ],
            [
                33.16,
                1707109200
            ],
            [
                33.27,
                1707195600
            ],
            [
                32.55,
                1707282000
            ],
            [
                32.1,
                1707368400
            ],
            [
                32.31,
                1707454800
            ],
            [
                32.6,
                1707714000
            ],
            [
                32.13,
                1707800400
            ],
            [
                32.02,
                1707886800
            ],
            [
                32.1,
                1707973200
            ],
            [
                32.28,
                1708059600
            ],
            [
                32.74,
                1708405200
            ],
            [
                32.91,
                1708491600
            ],
            [
                32.49,
                1708578000
            ],
            [
                32.96,
                1708664400
            ],
            [
                32.52,
                1708923600
            ],
            [
                33.03,
                1709010000
            ],
            [
                32.93,
                1709096400
            ],
            [
                32.73,
                1709182800
            ],
            [
                33.08,
                1709269200
            ],
            [
                32.88,
                1709528400
            ],
            [
                33.15,
                1709614800
            ],
            [
                33.47,
                1709701200
            ],
            [
                33.77,
                1709787600
            ],
            [
                33.9,
                1709874000
            ],
            [
                34.61,
                1710129600
            ],
            [
                35.15,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 3590,
        "drug_name": "TEGSEDI (inotersen)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "NEURO-TTR - familial amyloid polyneuropathy (FAP).",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2018-10-05",
        "link": "http:\/\/ir.akceatx.com\/news-releases\/news-release-details\/akcea-and-ionis-receive-fda-approval-tegseditm-inotersen",
        "note": "FDA Approval announced October 5, 2018,",
        "company_entity_id": 173,
        "company_ticker": "IONS",
        "company_name": "Ionis Pharmaceuticals Inc.",
        "company_price": "43.1700",
        "company_change": -0.08999999999999997,
        "company_percent_change": -0.20999999999999996,
        "company_optionable": 1,
        "company_number_of_shares": 145751797,
        "price_change_sparkline": [
            [
                51.39,
                1706677200
            ],
            [
                50.97,
                1706763600
            ],
            [
                49.75,
                1706850000
            ],
            [
                49.43,
                1707109200
            ],
            [
                49.12,
                1707195600
            ],
            [
                49.54,
                1707282000
            ],
            [
                49.98,
                1707368400
            ],
            [
                51.4,
                1707454800
            ],
            [
                50.38,
                1707714000
            ],
            [
                48.61,
                1707800400
            ],
            [
                49.07,
                1707886800
            ],
            [
                45.28,
                1707973200
            ],
            [
                44.43,
                1708059600
            ],
            [
                44.35,
                1708405200
            ],
            [
                43.53,
                1708491600
            ],
            [
                43.98,
                1708578000
            ],
            [
                45.36,
                1708664400
            ],
            [
                46.1,
                1708923600
            ],
            [
                47.41,
                1709010000
            ],
            [
                46.54,
                1709096400
            ],
            [
                45.21,
                1709182800
            ],
            [
                45.46,
                1709269200
            ],
            [
                44.87,
                1709528400
            ],
            [
                44.19,
                1709614800
            ],
            [
                44.29,
                1709701200
            ],
            [
                44.67,
                1709787600
            ],
            [
                43.99,
                1709874000
            ],
            [
                43.26,
                1710129600
            ],
            [
                43.17,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 2778,
        "drug_name": "JEMDEL1 (halobetasol propionate 0.01%)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Psoriasis",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2018-10-08",
        "link": "https:\/\/ir.bauschhealth.com\/news-releases\/2018\/10-08-2018-120019643",
        "note": "Tentative FDA Approval announced October 8, 2018. Final approval expected November 2018 pending the expiration of exclusivity for a related product.",
        "company_entity_id": 574,
        "company_ticker": "BHC",
        "company_name": "Bausch Health Companies Inc.",
        "company_price": "9.1900",
        "company_change": 0.07,
        "company_percent_change": 0.77,
        "company_optionable": 1,
        "company_number_of_shares": 365411953,
        "price_change_sparkline": [
            [
                7.85,
                1706677200
            ],
            [
                7.98,
                1706763600
            ],
            [
                7.92,
                1706850000
            ],
            [
                7.77,
                1707109200
            ],
            [
                8.13,
                1707195600
            ],
            [
                8.12,
                1707282000
            ],
            [
                8.13,
                1707368400
            ],
            [
                8.21,
                1707454800
            ],
            [
                8.38,
                1707714000
            ],
            [
                8.41,
                1707800400
            ],
            [
                8.43,
                1707886800
            ],
            [
                8.49,
                1707973200
            ],
            [
                8.51,
                1708059600
            ],
            [
                8.6,
                1708405200
            ],
            [
                8.67,
                1708491600
            ],
            [
                9.3,
                1708578000
            ],
            [
                9.18,
                1708664400
            ],
            [
                8.99,
                1708923600
            ],
            [
                9.18,
                1709010000
            ],
            [
                9.2,
                1709096400
            ],
            [
                9.39,
                1709182800
            ],
            [
                9.89,
                1709269200
            ],
            [
                9.58,
                1709528400
            ],
            [
                9.56,
                1709614800
            ],
            [
                9.23,
                1709701200
            ],
            [
                9.28,
                1709787600
            ],
            [
                9.23,
                1709874000
            ],
            [
                9.12,
                1710129600
            ],
            [
                9.19,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 4878,
        "drug_name": "GARDASIL 9",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Human Papilloma virus vaccine",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2018-10-09",
        "link": "https:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm622715.htm",
        "note": "Approval announced October 5, 2018.",
        "company_entity_id": 383,
        "company_ticker": "MRK",
        "company_name": "Merck & Company Inc.",
        "company_price": "122.6600",
        "company_change": -0.10999999999999999,
        "company_percent_change": -0.08999999999999997,
        "company_optionable": 1,
        "company_number_of_shares": 2532643872,
        "price_change_sparkline": [
            [
                120.78,
                1706677200
            ],
            [
                126.38,
                1706763600
            ],
            [
                126.41,
                1706850000
            ],
            [
                126.18,
                1707109200
            ],
            [
                126.88,
                1707195600
            ],
            [
                127.47,
                1707282000
            ],
            [
                126.61,
                1707368400
            ],
            [
                125.45,
                1707454800
            ],
            [
                125.34,
                1707714000
            ],
            [
                125.43,
                1707800400
            ],
            [
                125.82,
                1707886800
            ],
            [
                126.54,
                1707973200
            ],
            [
                127.79,
                1708059600
            ],
            [
                127.37,
                1708405200
            ],
            [
                128.12,
                1708491600
            ],
            [
                129.26,
                1708578000
            ],
            [
                129.45,
                1708664400
            ],
            [
                128.84,
                1708923600
            ],
            [
                129.03,
                1709010000
            ],
            [
                128.19,
                1709096400
            ],
            [
                127.15,
                1709182800
            ],
            [
                126.96,
                1709269200
            ],
            [
                124.05,
                1709528400
            ],
            [
                122.83,
                1709614800
            ],
            [
                123.75,
                1709701200
            ],
            [
                123.99,
                1709787600
            ],
            [
                123.5,
                1709874000
            ],
            [
                122.77,
                1710129600
            ],
            [
                122.66,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 4753,
        "drug_name": "YUTIQ (fluocinolone acetonide intravitreal implant)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Non-infectious uveitis",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2018-10-15",
        "link": "http:\/\/investors.eyepointpharma.com\/news-releases\/news-release-details\/eyepoint-pharmaceuticals-receives-fda-approval-yutiqtm",
        "note": "FDA approval announced October 15, 2018.",
        "company_entity_id": 30,
        "company_ticker": "ALIM",
        "company_name": "Alimera Sciences Inc.",
        "company_price": "3.8300",
        "company_change": 0.06,
        "company_percent_change": 1.5899999999999999,
        "company_optionable": 1,
        "company_number_of_shares": 52354450,
        "price_change_sparkline": [
            [
                3.65,
                1706677200
            ],
            [
                3.82,
                1706763600
            ],
            [
                3.89,
                1706850000
            ],
            [
                3.79,
                1707109200
            ],
            [
                3.85,
                1707195600
            ],
            [
                3.98,
                1707282000
            ],
            [
                3.89,
                1707368400
            ],
            [
                3.89,
                1707454800
            ],
            [
                3.83,
                1707714000
            ],
            [
                3.78,
                1707800400
            ],
            [
                3.34,
                1707886800
            ],
            [
                3.4,
                1707973200
            ],
            [
                3.42,
                1708059600
            ],
            [
                3.4,
                1708405200
            ],
            [
                3.25,
                1708491600
            ],
            [
                3.31,
                1708578000
            ],
            [
                3.37,
                1708664400
            ],
            [
                3.38,
                1708923600
            ],
            [
                3.5,
                1709010000
            ],
            [
                3.34,
                1709096400
            ],
            [
                3.54,
                1709182800
            ],
            [
                3.71,
                1709269200
            ],
            [
                3.72,
                1709528400
            ],
            [
                3.78,
                1709614800
            ],
            [
                3.87,
                1709701200
            ],
            [
                3.9,
                1709787600
            ],
            [
                3.97,
                1709874000
            ],
            [
                3.77,
                1710129600
            ],
            [
                3.83,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 4753,
        "drug_name": "YUTIQ (fluocinolone acetonide intravitreal implant)",
        "clinical_trial_id": null,
        "has_trial_insight_page": 0,
        "indication": "Non-infectious uveitis",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2018-10-15",
        "link": "http:\/\/investors.eyepointpharma.com\/news-releases\/news-release-details\/eyepoint-pharmaceuticals-receives-fda-approval-yutiqtm",
        "note": "FDA approval announced October 15, 2018.",
        "company_entity_id": 580,
        "company_ticker": "EYPT",
        "company_name": "EyePoint Pharmaceuticals Inc.",
        "company_price": "22.8100",
        "company_change": -0.06000000000000005,
        "company_percent_change": -0.26,
        "company_optionable": 1,
        "company_number_of_shares": 49830792,
        "price_change_sparkline": [
            [
                26.93,
                1706677200
            ],
            [
                28.51,
                1706763600
            ],
            [
                28.7,
                1706850000
            ],
            [
                27.79,
                1707109200
            ],
            [
                28.87,
                1707195600
            ],
            [
                29.37,
                1707282000
            ],
            [
                29.12,
                1707368400
            ],
            [
                28.8,
                1707454800
            ],
            [
                29.71,
                1707714000
            ],
            [
                29.63,
                1707800400
            ],
            [
                28.92,
                1707886800
            ],
            [
                29.08,
                1707973200
            ],
            [
                28.31,
                1708059600
            ],
            [
                27.705,
                1708405200
            ],
            [
                26.63,
                1708491600
            ],
            [
                26.1,
                1708578000
            ],
            [
                26.545,
                1708664400
            ],
            [
                26.55,
                1708923600
            ],
            [
                28.67,
                1709010000
            ],
            [
                27.68,
                1709096400
            ],
            [
                27.21,
                1709182800
            ],
            [
                28,
                1709269200
            ],
            [
                25.91,
                1709528400
            ],
            [
                25.57,
                1709614800
            ],
            [
                25.74,
                1709701200
            ],
            [
                25.31,
                1709787600
            ],
            [
                24.4,
                1709874000
            ],
            [
                22.87,
                1710129600
            ],
            [
                22.81,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 2813,
        "drug_name": "TALZENNA  (Talazoparib)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "BRCA-mutated breast cancer",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2018-10-16",
        "link": "https:\/\/www.fda.gov\/Drugs\/InformationOnDrugs\/ApprovedDrugs\/ucm623540.htm",
        "note": "FDA Approval announced October 16, 2018.",
        "company_entity_id": 387,
        "company_ticker": "PFE",
        "company_name": "Pfizer Inc.",
        "company_price": "28.0100",
        "company_change": -0.36,
        "company_percent_change": -1.27,
        "company_optionable": 1,
        "company_number_of_shares": 5646778425,
        "price_change_sparkline": [
            [
                27.08,
                1706677200
            ],
            [
                27.29,
                1706763600
            ],
            [
                26.93,
                1706850000
            ],
            [
                26.57,
                1707109200
            ],
            [
                27.5,
                1707195600
            ],
            [
                27.56,
                1707282000
            ],
            [
                27.57,
                1707368400
            ],
            [
                27.56,
                1707454800
            ],
            [
                27.66,
                1707714000
            ],
            [
                26.97,
                1707800400
            ],
            [
                27.11,
                1707886800
            ],
            [
                27.51,
                1707973200
            ],
            [
                27.62,
                1708059600
            ],
            [
                27.59,
                1708405200
            ],
            [
                27.67,
                1708491600
            ],
            [
                27.55,
                1708578000
            ],
            [
                27.76,
                1708664400
            ],
            [
                27.18,
                1708923600
            ],
            [
                26.89,
                1709010000
            ],
            [
                27.04,
                1709096400
            ],
            [
                26.56,
                1709182800
            ],
            [
                26.59,
                1709269200
            ],
            [
                25.89,
                1709528400
            ],
            [
                26.08,
                1709614800
            ],
            [
                27.19,
                1709701200
            ],
            [
                26.79,
                1709787600
            ],
            [
                27.22,
                1709874000
            ],
            [
                28.37,
                1710129600
            ],
            [
                28.01,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 2786,
        "drug_name": "DUPIXENT (dupilumab)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Asthma",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2018-10-19",
        "link": "https:\/\/investor.regeneron.com\/news-releases\/news-release-details\/fda-approves-asthma-indication-dupixentr-dupilumab",
        "note": "FDA approval announced October 19, 2018.",
        "company_entity_id": 388,
        "company_ticker": "REGN",
        "company_name": "Regeneron Pharmaceuticals Inc.",
        "company_price": "970.5700",
        "company_change": 6.13,
        "company_percent_change": 0.64,
        "company_optionable": 1,
        "company_number_of_shares": 109761896,
        "price_change_sparkline": [
            [
                942.78,
                1706677200
            ],
            [
                957.78,
                1706763600
            ],
            [
                945.18,
                1706850000
            ],
            [
                936.33,
                1707109200
            ],
            [
                937.81,
                1707195600
            ],
            [
                938.49,
                1707282000
            ],
            [
                946.43,
                1707368400
            ],
            [
                953.42,
                1707454800
            ],
            [
                947.06,
                1707714000
            ],
            [
                940.48,
                1707800400
            ],
            [
                947.82,
                1707886800
            ],
            [
                954.73,
                1707973200
            ],
            [
                948.05,
                1708059600
            ],
            [
                946.87,
                1708405200
            ],
            [
                952.84,
                1708491600
            ],
            [
                964.89,
                1708578000
            ],
            [
                981.2,
                1708664400
            ],
            [
                989.28,
                1708923600
            ],
            [
                993.35,
                1709010000
            ],
            [
                987.61,
                1709096400
            ],
            [
                966.09,
                1709182800
            ],
            [
                982.82,
                1709269200
            ],
            [
                971.19,
                1709528400
            ],
            [
                965.21,
                1709614800
            ],
            [
                972.1,
                1709701200
            ],
            [
                973.31,
                1709787600
            ],
            [
                968.83,
                1709874000
            ],
            [
                964.44,
                1710129600
            ],
            [
                970.57,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 2786,
        "drug_name": "DUPIXENT (dupilumab)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Asthma",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2018-10-19",
        "link": "https:\/\/investor.regeneron.com\/news-releases\/news-release-details\/fda-approves-asthma-indication-dupixentr-dupilumab",
        "note": "FDA approval announced October 19, 2018.",
        "company_entity_id": 389,
        "company_ticker": "SNY",
        "company_name": "Sanofi",
        "company_price": "48.4600",
        "company_change": 0.11,
        "company_percent_change": 0.23,
        "company_optionable": 1,
        "company_number_of_shares": 2529599938,
        "price_change_sparkline": [
            [
                49.9,
                1706677200
            ],
            [
                48.41,
                1706763600
            ],
            [
                47.23,
                1706850000
            ],
            [
                46.95,
                1707109200
            ],
            [
                47.06,
                1707195600
            ],
            [
                46.92,
                1707282000
            ],
            [
                46.56,
                1707368400
            ],
            [
                46.5,
                1707454800
            ],
            [
                46.34,
                1707714000
            ],
            [
                45.75,
                1707800400
            ],
            [
                45.8,
                1707886800
            ],
            [
                46.39,
                1707973200
            ],
            [
                46.18,
                1708059600
            ],
            [
                46.85,
                1708405200
            ],
            [
                47.92,
                1708491600
            ],
            [
                47.8,
                1708578000
            ],
            [
                48.77,
                1708664400
            ],
            [
                48.2,
                1708923600
            ],
            [
                48.21,
                1709010000
            ],
            [
                48,
                1709096400
            ],
            [
                47.85,
                1709182800
            ],
            [
                47.29,
                1709269200
            ],
            [
                47.15,
                1709528400
            ],
            [
                47.5,
                1709614800
            ],
            [
                47.68,
                1709701200
            ],
            [
                48.06,
                1709787600
            ],
            [
                48.25,
                1709874000
            ],
            [
                48.35,
                1710129600
            ],
            [
                48.46,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 4934,
        "drug_name": "XOFLUZA (baloxavir marboxil)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Influenza",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2018-10-24",
        "link": "https:\/\/www.roche.com\/media\/releases\/med-cor-2018-10-24.htm",
        "note": "FDA Approval announced October 24, 2018.",
        "company_entity_id": 536,
        "company_ticker": "RHHBY",
        "company_name": "Roche Holding AG ADR",
        "company_price": "35.1500",
        "company_change": 0.54,
        "company_percent_change": 1.56,
        "company_optionable": 0,
        "company_number_of_shares": 6389213336,
        "price_change_sparkline": [
            [
                35.14,
                1706677200
            ],
            [
                34.32,
                1706763600
            ],
            [
                33.95,
                1706850000
            ],
            [
                33.16,
                1707109200
            ],
            [
                33.27,
                1707195600
            ],
            [
                32.55,
                1707282000
            ],
            [
                32.1,
                1707368400
            ],
            [
                32.31,
                1707454800
            ],
            [
                32.6,
                1707714000
            ],
            [
                32.13,
                1707800400
            ],
            [
                32.02,
                1707886800
            ],
            [
                32.1,
                1707973200
            ],
            [
                32.28,
                1708059600
            ],
            [
                32.74,
                1708405200
            ],
            [
                32.91,
                1708491600
            ],
            [
                32.49,
                1708578000
            ],
            [
                32.96,
                1708664400
            ],
            [
                32.52,
                1708923600
            ],
            [
                33.03,
                1709010000
            ],
            [
                32.93,
                1709096400
            ],
            [
                32.73,
                1709182800
            ],
            [
                33.08,
                1709269200
            ],
            [
                32.88,
                1709528400
            ],
            [
                33.15,
                1709614800
            ],
            [
                33.47,
                1709701200
            ],
            [
                33.77,
                1709787600
            ],
            [
                33.9,
                1709874000
            ],
            [
                34.61,
                1710129600
            ],
            [
                35.15,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 2886,
        "drug_name": "XYREM (sodium oxybate)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Pediatric narcolepsy patients with cataplexy",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2018-10-26",
        "link": "https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/021196s030lbl.pdf",
        "note": "FDA Approval announced October 26, 2018.",
        "company_entity_id": 381,
        "company_ticker": "JAZZ",
        "company_name": "Jazz Pharmaceuticals plc",
        "company_price": "115.7900",
        "company_change": -0.84,
        "company_percent_change": -0.72,
        "company_optionable": 1,
        "company_number_of_shares": 62345283,
        "price_change_sparkline": [
            [
                122.72,
                1706677200
            ],
            [
                123.68,
                1706763600
            ],
            [
                122.9,
                1706850000
            ],
            [
                121.98,
                1707109200
            ],
            [
                124.71,
                1707195600
            ],
            [
                122.94,
                1707282000
            ],
            [
                122.67,
                1707368400
            ],
            [
                123.43,
                1707454800
            ],
            [
                124.24,
                1707714000
            ],
            [
                121.83,
                1707800400
            ],
            [
                122.24,
                1707886800
            ],
            [
                126.82,
                1707973200
            ],
            [
                126.78,
                1708059600
            ],
            [
                126.36,
                1708405200
            ],
            [
                128.42,
                1708491600
            ],
            [
                128.45,
                1708578000
            ],
            [
                132.28,
                1708664400
            ],
            [
                132.77,
                1708923600
            ],
            [
                132.26,
                1709010000
            ],
            [
                129.7,
                1709096400
            ],
            [
                118.9,
                1709182800
            ],
            [
                118.85,
                1709269200
            ],
            [
                117.53,
                1709528400
            ],
            [
                118.42,
                1709614800
            ],
            [
                117.19,
                1709701200
            ],
            [
                116.37,
                1709787600
            ],
            [
                117.53,
                1709874000
            ],
            [
                116.63,
                1710129600
            ],
            [
                115.79,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 3145,
        "drug_name": "BIJUVA (estradiol and progesterone)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Moderate to severe vasomotor symptoms (VMS)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2018-10-29",
        "link": "http:\/\/ir.therapeuticsmd.com\/news-releases\/news-release-details\/therapeuticsmd-announces-fda-approval-tx-001hr-bijuvatm",
        "note": "FDA approval announced October 29, 2018.",
        "company_entity_id": 327,
        "company_ticker": "TXMD",
        "company_name": "TherapeuticsMD Inc.",
        "company_price": "2.3850",
        "company_change": 0.16,
        "company_percent_change": 6.95,
        "company_optionable": 1,
        "company_number_of_shares": 10575240,
        "price_change_sparkline": [
            [
                2.26,
                1706677200
            ],
            [
                2.26,
                1706763600
            ],
            [
                2.27,
                1706850000
            ],
            [
                2.29,
                1707109200
            ],
            [
                2.29,
                1707195600
            ],
            [
                2.27,
                1707282000
            ],
            [
                2.29,
                1707368400
            ],
            [
                2.29,
                1707454800
            ],
            [
                2.25,
                1707714000
            ],
            [
                2.24,
                1707800400
            ],
            [
                2.29,
                1707886800
            ],
            [
                2.24,
                1707973200
            ],
            [
                2.26,
                1708059600
            ],
            [
                2.27,
                1708405200
            ],
            [
                2.26,
                1708491600
            ],
            [
                2.26,
                1708578000
            ],
            [
                2.25,
                1708664400
            ],
            [
                2.29,
                1708923600
            ],
            [
                2.35,
                1709010000
            ],
            [
                2.37,
                1709096400
            ],
            [
                2.4,
                1709182800
            ],
            [
                2.54,
                1709269200
            ],
            [
                2.635,
                1709528400
            ],
            [
                2.69,
                1709614800
            ],
            [
                2.45,
                1709701200
            ],
            [
                2.29,
                1709787600
            ],
            [
                2.33,
                1709874000
            ],
            [
                2.23,
                1710129600
            ],
            [
                2.385,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 4721,
        "drug_name": "KEYTRUDA (pembrolizumab) + TAXOL\/CARBO or ABRAXANE (nab-paclitaxel)",
        "clinical_trial_id": "NCT02775435",
        "has_trial_insight_page": 0,
        "indication": "Squamous non-small cell lung cancer (sNSCLC)",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2018-10-30",
        "link": "https:\/\/bit.ly\/2OiztLo",
        "note": "FDA approval announced October 30, 2018.",
        "company_entity_id": 383,
        "company_ticker": "MRK",
        "company_name": "Merck & Company Inc.",
        "company_price": "122.6600",
        "company_change": -0.10999999999999999,
        "company_percent_change": -0.08999999999999997,
        "company_optionable": 1,
        "company_number_of_shares": 2532643872,
        "price_change_sparkline": [
            [
                120.78,
                1706677200
            ],
            [
                126.38,
                1706763600
            ],
            [
                126.41,
                1706850000
            ],
            [
                126.18,
                1707109200
            ],
            [
                126.88,
                1707195600
            ],
            [
                127.47,
                1707282000
            ],
            [
                126.61,
                1707368400
            ],
            [
                125.45,
                1707454800
            ],
            [
                125.34,
                1707714000
            ],
            [
                125.43,
                1707800400
            ],
            [
                125.82,
                1707886800
            ],
            [
                126.54,
                1707973200
            ],
            [
                127.79,
                1708059600
            ],
            [
                127.37,
                1708405200
            ],
            [
                128.12,
                1708491600
            ],
            [
                129.26,
                1708578000
            ],
            [
                129.45,
                1708664400
            ],
            [
                128.84,
                1708923600
            ],
            [
                129.03,
                1709010000
            ],
            [
                128.19,
                1709096400
            ],
            [
                127.15,
                1709182800
            ],
            [
                126.96,
                1709269200
            ],
            [
                124.05,
                1709528400
            ],
            [
                122.83,
                1709614800
            ],
            [
                123.75,
                1709701200
            ],
            [
                123.99,
                1709787600
            ],
            [
                123.5,
                1709874000
            ],
            [
                122.77,
                1710129600
            ],
            [
                122.66,
                1710216000
            ]
        ],
        "statuses": []
    },
    {
        "id": 2873,
        "drug_name": "INVOKANA (canagliflozin)",
        "clinical_trial_id": "",
        "has_trial_insight_page": 0,
        "indication": "Type 2 diabetes",
        "label": "Approved",
        "value": "approved",
        "simplified_stage": "phase6",
        "stageid": 15,
        "stage_name": "Approved",
        "date": "2018-10-30",
        "link": "http:\/\/files.shareholder.com\/downloads\/JNJ\/6400367891x0x984510\/15609F03-ACE3-4193-9328-27EACF35566E\/INVOKANA_CANVAS_FDA_Approval_Final_10.30.18.pdf",
        "note": "FDA Approval announced October 30, 2018.",
        "company_entity_id": 380,
        "company_ticker": "JNJ",
        "company_name": "Johnson & Johnson",
        "company_price": "162.7400",
        "company_change": 1.51,
        "company_percent_change": 0.94,
        "company_optionable": 1,
        "company_number_of_shares": 2408767228,
        "price_change_sparkline": [
            [
                157.701248890579,
                1706677200
            ],
            [
                157.165322682896,
                1706763600
            ],
            [
                155.428524787625,
                1706850000
            ],
            [
                154.6246354761,
                1707109200
            ],
            [
                156.867585900849,
                1707195600
            ],
            [
                156.788189425637,
                1707282000
            ],
            [
                155.220109040193,
                1707368400
            ],
            [
                155.577393178648,
                1707454800
            ],
            [
                156.659170153417,
                1707714000
            ],
            [
                155.289580956004,
                1707800400
            ],
            [
                154.565088119691,
                1707886800
            ],
            [
                156.728642069228,
                1707973200
            ],
            [
                156.55,
                1708059600
            ],
            [
                157.86,
                1708405200
            ],
            [
                158.68,
                1708491600
            ],
            [
                160.45,
                1708578000
            ],
            [
                161.84,
                1708664400
            ],
            [
                160.79,
                1708923600
            ],
            [
                160.98,
                1709010000
            ],
            [
                161.55,
                1709096400
            ],
            [
                161.38,
                1709182800
            ],
            [
                162.12,
                1709269200
            ],
            [
                159.84,
                1709528400
            ],
            [
                159.97,
                1709614800
            ],
            [
                159.34,
                1709701200
            ],
            [
                158.87,
                1709787600
            ],
            [
                159.52,
                1709874000
            ],
            [
                161.23,
                1710129600
            ],
            [
                162.74,
                1710216000
            ]
        ],
        "statuses": []
    }
]